Here are six initiatives launched in 2019 in pursuit of that expansion, beginning with the most recent:
1. The Partnership for Artificial Intelligence, Telemedicine and Robotics in Healthcare released a set of ethical guidelines for the development of AI in healthcare, based partly on existing statements such as the Hippocratic Oath and Asilomar AI Principle.
2. The White House updated its National AI Research and Development Strategic Plan, reinforcing the importance of considering the ethical implications of the advancement and deployment of AI.
3. Stephen Schwarzman, founder and CEO of investment firm Blackstone, donated nearly $200 million to Oxford University to establish the Stephen A. Schwarzman Centre for the Humanities, which will be home to a new Institute for Ethics in Artificial Intelligence.
4. A team of ethics researchers published a report in Neuron decrying the dangerously unfounded claims often made by the companies behind wearable neurotechnology devices. “Scientific evidence is essential to legitimize claims about utility, safety and efficacy and for informed choice and public trust,” they wrote.
5. Researchers from MIT’s computer science and AI lab launched a project seeking to “de-bias” AI by resampling the data fed into algorithms to be more balanced.
6. Google released a white paper describing how governments, civil society groups and developers must work together to define and clarify ethical questions regarding AI. These parties, they wrote, should direct their focus especially toward the areas of explainability standards, fairness appraisal, safety considerations, human-AI collaboration and liability frameworks.
More articles about AI:
Beth Israel Deaconess’ open-source patient database enabled a decade of AI research
VA appoints 1st director of AI, plans to expand AI research: 4 notes
6 hospital applications for machine learning: algorithms to predict patient violence, HIV risk & more
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
